Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Amyloid β-Peptide (1-42) (human)

Catalog No.
B6057
A 42-amino-acid peptide that plays a key role in the pathogenesis of Alzheimer's disease, commonly used to construct Alzheimer's disease (AD) animal models.
Grouped product items
Size Price Stock Qty
1mg
$285.00
In stock
5mg
$780.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Amyloid beta-Peptide (1-42) (human) (CAS 107761-42-2) is a 42-amino-acid peptide that plays a key role in the pathogenesis of Alzheimer's disease (AD) [1].

Its major deleterious effects in pathogenesis may be mediated by Aβ42, which acts as a repressor or activator of gene transcription, leading to further synaptic dysfunction and neuronal degeneration [2].

When Aβ42 concentration reaches 2.5 μM, the survival rate of SH-SY5Y cells drops to 65%. Using chromatin immunoprecipitation (ChIP) and qRT-PCR assays, treatment of SH-SY5Y cells with Aβ42 enables the peptide to bind the LRP1 and KAI1 promoters simultaneously and elevates APP mRNA levels; in contrast, the non-toxic Aβ42 G33A peptide, which is abundant in the nucleus, has no effect on mRNA expression. Compared with several peptides of different lengths, Aβ42 treatment specifically increases the transcription and expression of its precursor gene APP [1].

Aβ42 participates in regulating voltage-gated Ca2+ and K+ channel functions on the neuronal surface membrane. Applied in the perfusate at appropriate concentrations (1 to 10 μM), Aβ42 has no effect on delayed rectifier K+ currents and leak currents but enhances the inactivation of Ca2+ currents and blocks Ca2+-dependent K+ currents [3].

Amyloid beta-Peptide (1-42) is commonly used to establish Alzheimer's disease (AD) animal models, and intracerebral injection induces neuronal damage and learning and memory dysfunction.

References

[1] Barucker C, Harmeier A, Weiske J, et al. Nuclear Translocation Uncovers the Amyloid Peptide Aβ42 as a Regulator of Gene Transcription. The journal of biological chemistry, 2014, 289(29): 20182-20191.

[2] Hardy J and Selkoe D J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297(5580): 353-356.

[3] Solntseva E I, Bukanova J V, Marchenko E V, et al. Impact of Amyloid-β Peptide (1-42) on Voltage-Gated Ion Currents in Molluscan Neurons. Bulletin of experimental biology and medicine, 2011, 151(6): 671-674.

Product Citation

Chemical Properties

StorageStore at -20°C
M.Wt4514.08
Cas No.107761-42-2
FormulaC203H311N55O60S
Synonymsβ-Amyloid (1-42), human TFA
Solubilityinsoluble in H2O; insoluble in EtOH; ≥40.5 mg/mL in DMSO
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

User Guide